ung aeration and Lung perfusion Before and After Electrocardioversio
Completed
- Conditions
- atelectasis and lung perfusion1000752110024967
- Registration Number
- NL-OMON37853
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Hemodynamically stable patients coming for electrocardioversion because of atrial fibrillation
Exclusion Criteria
o Age < 18 years
o Presence of a pacemaker
o Presence of an automatic cardiac defibrillator
o Presence of any implantable pumps
o History of chronic obstructive pulmonary disease (COPD - defined as a forced
expiratory volume in 1 second to a forced vital capacity ratio less than 0.65 and daily medication), restrictive pulmonary disease (evidence of chronic interstitial infiltration on chest radiograph), pulmonary thrombo-embolism, previous pneumectomy or lobectomy
o Known chronic or decompensated heart failure
o MET score <6
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study endpoint is the change in regional lung aeration before and<br /><br>after ECV, assessed by EIT.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary study endpoint is the change in regional lung perfusion before and<br /><br>after ECV, assessed by EIT.</p><br>